semaglutide and breastfeeding (Ozempic) use during – concerns related to rapid weight loss, not the drug itself Weight loss injections and breastfeeding.

Introduction The development of new compounds in recent decades has substantially improved the pharmacotherapy of type 2 diabetes (T2D) by improving achievement of metabolic targets while mitigating specific side effects (e.g., weight gain, hypoglycemia) frequently observed in patients treated with traditional hypoglycemic drugs such as insulin and sulfonylureas

Ref: Maciej Lukawski (2019)

For functional medicine practitioners, biohackers, and researchers, DSIP represents an exciting tool in the expanding toolkit for restoring sleep, rebuilding resilience, and enhancing healthspan

Large portions may cause discomfort because GLP-1s slow digestion

Guidelines provided by Cochrane reviews which tested sensitivity and specificity at a fixed cutoff point of 80% for both parameters were used to compare dermoscopy versus eye inspection

These include Plan F, G, and N